FDA Approves Inhalable Diabetes Drug Afrezza
Scott Benner
I want to be 100% clear that my next statement is based on absolutely nothing but my gut instinct. I may very well be completely wrong but...
I would never let Arden inhale insulin, it just doesn't sound like a good idea to me.
That said, I hope that I'm wrong and that this helps countless people...
From ABC News/AP News
The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals.
The FDA cleared MannKind Corp.'s drug Afrezza, a fast-acting form of insulin, for adults with the most common form of diabetes that affects more than 25 million Americans. The approval decision comes more than three years after the agency first asked MannKind to run additional clinical studies on the drug.
The rest of this news story can be found here.
The FDA News release is here.
More blog posts you may enjoy
Caregiving, Connection, and Coping – Inside the Juicebox Podcast's Caregiver Burnout Series
Source
Comment